Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Laughing in my bunker, thanks.
There is no excuse, just an admission of failure. Children make excuses, adults get results or own up to failure. That is how the real world works.
180 days was plenty of time to accomplish something, Andy set the table for Full Clearance, not BIEL 2.0.
BIEL should be making and selling product, not excuses.How many times did I post BIEL should make deals while the market was booming?
180 days is KW's own self imposed metric.
Day 151.
Less than a month left.
Day 150
Ain't no BSing with Time, ask Cher and Madonna.
Every intelligent person knew the market was a bubble. 180 days was given as a deadline. Excuses are meaningless.
Day 149.
I wonder how much the competitor Dr. Robert Fishell learned on his tour?
Oh yeah, waiting on that South African money to start rolling in. Average per capita income $13,000.
P
Mr. Whelan died on October 7th, 2019, so I'm giving some lag days to be fair.
I asked for input before I started the count, and got none, so please do your own countdown if you disagree with mine.
Day 148.
Day 147
Money talks, BS walks the marathon.
in the past, I often encouraged BIEL to make deals while the economy was peaking.
True visionaries would have foreseen market upheavals, so there is no excuse for KW not hitting the 180 metric she assigned to herself, In business, there are only two types of people--the ones who do what they say they will and the ones who don't.
Day 146.
Either results or excuses are pending.
This was a self-imposed metric.
Results=BIEL 2.0
Excuses=Even BIEL 1.0 needs a patch. I suggest Dr.Fischell. Notice his visit went down the memory hole when I started nominating him for CEO.
Day 144
Let's see if talk is cheap or not. Live up to your own metrics, BIEL.
Day 143
Day 142
My mistake.
Day 141
Day 141
The same yes man corporate culture as 1.0, and how far did that get us?
A long time poster was saying news Monday or today. Sometimes credibility will be sacrificed to stem a panic, lets hope this wasn't the case.
Day 140
Starting from October 15th.
Hoping we get that promised news release tomorrow. 140 days and 1 elderly visitor whom I am hoping will take over.
Sounds like a changing of the guard is imminent.
Thank you for your service, KW!
So our latest hyped up messiah is really just a bored old codger?
That man is a legend, and could set BIEL up for success with just 60 days at the helm. Talent is what you are born with, it does not come from lived experience.
It's just rumor then. Some were suggesting that if KW fails to meet the 180 day deadline (her own metric) for accomplishing something, she would step aside for Dr. Fischel, who people here are really giddy about, from all the posts. Otherwise giving a competitor a free tour seems unwise, but they seem to have plenty of free time at BIEL.
Day 140, 40 more to go for KW.
Wow, Fischell sounds like real CEO material!
Will Dr. Robert Fischel be the new CEO, or is that just another rumor?
Day 139.
Day 136
to be fair.
Day 144.
Post of the Week, winner winner, chicken dinner.
Day 143.
Before I had children, I didn't give an eff either, though I didn't need to read a book on how not to. Hopefully she gets bored with sitting in Daddy's office playing on Twitter soon.
Day 141 sounds about right.
What day is it? I figured there would be some accomplishments before Day 180.
Srin, I jotted down some ideas about this.
Key point-somebody from BIEL should call the FDA and ask why Livia can be marketed for period pain but not the Actipatch.
Livia’s justification for advertising itself as a dysmenorrhea pain treatment is possibly the chronic pain indication they have.
They probably feel they could target any kind of chronic pain and chose menstrual cramps as being the most lucrative.
Some of the studies I looked at compared TENS treatment for period pain to NSAIDs, as they are a typical pharmacological option for treating this pain. Since pills are absolutely generic, if BIEL also compares favorably to NSAIDs, BIEL should be able to sell the ActiPatch or whatever they are calling it this week for menstrual pain as well.
This is logical, where I am lost here is if the ActiPatch is a nerve treatment, applied to soft tissue, then BIEL could probably sell this for period pain without additional clearance, just a successful study they could reference, which has long been promised.
Not to be a snitch, but since BIEL seems sketchy about the specifics of the human nervous system, maybe they could mine the FDA for some useful information on the pretext of snitching on LIVIA? I think chronic pain sort of covers LIVIA, but why should the TENs crowd get to market their product taking such liberties with their indicated use while BIEL flounders due to not having their eye on the prize when it came to their application?
Livia has no more than “chronic pain” as far as I could tell to justify selling this to women for period pain.
Ask Sree if he knows there are different types of nerves. Maybe he could "expedite" an answer.
Hi, I'm mildly autistic, so I read everything literally:
"...Musculoskeletal pain is a consequence of cumulative trauma, repetitive strain or overuse and refers to pain in the muscles, bones, ligaments, tendons, and nerves..." (From BIEL's statement)
The statement indicates BIEL has clearance for all nerve pain, which is either true or is poorly written (I'm not calling them liars, though incomplete information can be interpreted as being deceptive.). What type of nerve pain should be indicated (for instance peripheral versus autonomic). Dumbing this down is not helpful.If BIEL got clearance for all nerve pain, then allay and migraine are already approved, is my point. If not, which nervous system they have it for should be specified.
"...Musculoskeletal pain is a consequence of cumulative trauma, repetitive strain or overuse and refers to pain in the muscles, bones, ligaments, tendons, and nerves..."
Poorly phrased. All pain is from the brain. The nerves carry signals to the brain. So all pain is nerve pain, by that standard. There is no menstrual pain,just nerves conducting signals to the brain signalling menstrual pain.
So if you can sell the FDA that the ActiPatch treats nerve pain, you just got full body clearance for all types of pain.
To illustrate, brain surgery requires no anesthetic. No nerves in the brain, so no pain.
The Actipatch does not regulate prostaglandins, but would alleviate pain associated with the unfertilized egg tearing from the endometrial walls it was attached to.
Essentially, the egg tears a type of muscle, There are different types.
The pain comes from muscle pain.
So basically 90% of what BIEL has been spending money on up to now was wasted effort, and they should have focused solely on licensing deals?
Full muskuloskeletal Clearance means all muscle systems.
BIEL's back study was rejected by the FDA because the study produced anomalous results based on gender. NOT because it negatively impacted kidneys, liver etc. Yet, now BIEL has full clearance and can sell for the back pain...because it got full muskuloskeletal clearance.
As for the migraine headaches, the Patch is still working the same way,treating muscle pain.
Menstrual pain is caused by muscle pain.
BIEL's product is safe. All BIEL has to do is word the ad carefully and it can advertise as treating any muscle pain with no further approval, including migraine,now that you mention it.
Migraine is easier sell than menstrual,because the FDA's first clearance was for eye plastic surgery pain, indicating there is no brain danger, or at least much,much less than cellphones. which the FDA has deemed safe.
I'm mainly interested in getting my Allay question answered than in rehashing previous ideas.
Namely, I don't think Allay needs further FDA approval Full muskuloskeletal is enough to market Allay legally. If not, why not?